Overall Technical outlook

Price Summary

Regeneron Pharmaceuticals, Inc.'s stock began trading at 734.61 on 2026-10-06, soared to 740.51, dipped to 727.16, and finished the day 0.56% higher at 738.72, with 615100 shares exchanged.
In the past year, the highest stock price was 852.03, and the lowest was 0.0.

Technicals

Support and Resistance: The price for REGN at 738.72 is supported by the 721.05 level and faces resistance at 747.36. This range indicates key levels where the price may find buyers near 721.05 and sellers near 747.36, defining a trading range.
REGN supportResistance 6e41d1
Support/Resistance for REGN
Aroon: The current reading of the AROON is neutral for REGN, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
REGN aroon 6e41d1
Aroon chart for Regeneron Pharmaceuticals, Inc.
Bol. Bands: The current reading of the BOLL BANDS is neutral for REGN, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
REGN bbands 6e41d1
Bolinger Bands chart for Regeneron Pharmaceuticals, Inc.
Parabolic SAR: The PSAR for REGN maintains a bullish outlook, establishing a crucial support level that may help maintain the current upward momentum. This strong support suggests that the market is poised to continue its upward trend, providing confidence in the ongoing bullish sentiment.
REGN psar 6e41d1
Parabolic Stop and Reverse chart for Regeneron Pharmaceuticals, Inc.
Stochastic: The stochastic indicator for Regeneron Pharmaceuticals, Inc. shows the K-line below the D-line but still above 80, hinting at the possible onset of a bearish price move. This could indicate that the market's recent strength is waning, with a potential downturn on the horizon. Traders should keep an eye on this development for further signs of weakness.
REGN stoch 6e41d1
Stochastic chart for Regeneron Pharmaceuticals, Inc.
Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, not indicating a clear upward or downward trend for Regeneron Pharmaceuticals, Inc.. This suggests a period of market balance, where neither side is showing dominance.
REGN trippleSMA 6e41d1
Tripple SMA chart for Regeneron Pharmaceuticals, Inc.

When analyzing a company, its fundamentals—such as earnings, management efficiency, and strategic initiatives—must be considered alongside technical data. The context of the industry in which the company operates also plays a key role, as market trends and competitive dynamics can significantly impact performance. By taking a comprehensive approach, combining both fundamental and technical analysis, one can gain a deeper understanding of the company's potential for growth or risk.